Curis Lifesciences Management
Management criteria checks 3/4
Curis Lifesciences' CEO is Dharmesh Patel, appointed in Nov 2024, has a tenure of 9.67 years. directly owns 13.61% of the company’s shares, worth ₹147.45M. The average tenure of the management team and the board of directors is 1 years and 9.7 years respectively.
Key information
Dharmesh Patel
Chief executive officer
₹600.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1yr |
| CEO ownership | 13.6% |
| Management average tenure | 1yr |
| Board average tenure | 9.7yrs |
Recent management updates
Recent updates
CEO
Dharmesh Patel (51 yo)
Mr. Dharmesh Dasharathbhai Patel is MD of Curis Lifesciences Limited from November 6, 2024 and serves as its Non-Executive Director on March 23, 2016 and serves as its Chairman since December 3, 2024. With...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Chairman | 1yr | ₹600.00k | 13.61% ₹ 147.5m | |
| Chief Financial Officer | 1yr | ₹769.00k | no data | |
| Company Secretary & Compliance Officer | 1yr | ₹118.00k | no data | |
| Whole-Time Director | 1yr | ₹600.00k | 12.93% ₹ 140.1m | |
| Whole-Time Director | 1yr | ₹600.00k | 15.65% ₹ 169.6m |
Experienced Management: CURIS's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Chairman | 9.7yrs | ₹600.00k | 13.61% ₹ 147.5m | |
| Whole-Time Director | 9.7yrs | ₹600.00k | 12.93% ₹ 140.1m | |
| Whole-Time Director | 9.7yrs | ₹600.00k | 15.65% ₹ 169.6m | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 1yr | no data | no data | |
| Non-Executive Director | 9.7yrs | no data | 25.85% ₹ 280.2m | |
| Independent Non-Executive Director | 1yr | no data | no data |
Experienced Board: CURIS's board of directors are considered experienced (9.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/20 16:03 |
| End of Day Share Price | 2025/11/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Curis Lifesciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.